Drug discovery and development timeline

Description:

The image is a PowerPoint slide titled "Drug Discovery and Development Timeline," which illustrates the typical stages and duration of developing a new pharmaceutical drug. The timeline is segmented into four phases:

1. Drug Discovery:

This initial phase involves screening approximately 15,000 compounds over an estimated period of 6.5 years to identify potential candidates for development.

2. Preclinical:

Out of the initial pool, around 500 compounds are selected to undergo preclinical testing. This stage typically spans about 7 years and includes laboratory and animal testing to evaluate safety.

3. Clinical Trials:

From the preclinical phase, roughly 10 compounds move on to clinical trials, which last around 1.5 years. These trials are conducted with human participants to assess efficacy and safety.

4. FDA Review:

Finally, the process culminates with the FDA review, where on average, only 1 drug is approved. The footnote clarifies that "FDA" stands for Food and Drug Administration.

Use Cases:

Drug development timeline is relevant and can be used across several industries related to pharmaceuticals and healthcare:

1. Pharmaceuticals:

Use: Educating on drug development processes

Presenter: R&D Director

Audience: Research scientists, new employees

2. Biotechnology:

Use: Illustrating the timeline for biotech drug development

Presenter: Biotech Project Manager

Audience: Investors, stakeholders

4. Healthcare Consulting:

Use: Advising healthcare businesses on product lifecycles

Presenter: Healthcare Consultant

Audience: Healthcare executives, strategy teams

5. Medical Education:

Use: Teaching students about the drug approval process

Presenter: Academic Professor

Audience: Medical and pharmacy students

6. Healthcare Investment:

Use: Assessing the timeline for drug market entry

Presenter: Financial Analyst

Audience: Investors, financial advisors

7. Regulatory Affairs:

Use: Training on the regulatory aspects of drug development

Presenter: Regulatory Affairs Specialist

Audience: Regulatory affairs teams, compliance officers

8. Healthcare Marketing:

Use: Preparing marketing strategies based on drug development stages

Presenter: Marketing Manager

Audience: Marketing teams, brand strategists